MET MetLife
Data as of close
MetLife (MET) is a financial company in the Life Insurance industry, with a market capitalization of $64.2 billion. Shares last traded at $100.95, near their 52-week high. Over the past year the stock is up 27.5%. MET trades at a price-to-earnings ratio of 17.69, above the Life Insurance median of 11.59. Net profit margin is 4.7%, below the peer median of 6.0%. Revenue grew 8.5% year over year. The shares yield 2.3% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
MET Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $1.51B | $2.24 | 48% |
| 2024-12-31 | $1.53B | $2.15 | 36% |
| 2023-12-31 | $1.57B | $2.05 | 113% |
| 2022-12-31 | $1.60B | $1.98 | 68% |
| 2021-12-31 | $1.65B | $1.89 | 26% |
| 2020-12-31 | $1.66B | $1.81 | 31% |
| 2019-12-31 | $1.64B | $1.74 | 28% |
| 2018-12-31 | $1.68B | $1.65 | 33% |
| 2017-12-31 | $1.72B | $1.59 | 43% |
| 2016-12-31 | $1.74B | $1.57 | 204% |
| 2015-12-31 | $1.65B | $1.47 | 31% |
| 2014-12-31 | $1.50B | $1.31 | 24% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $1.09 | 2026-08-06 |
| Q1 2026 | $1.74 | 2026-05-07 |
| Q4 2025 (derived) | $1.18 | 2026-02-19 |
| FY 2025 | $4.71 | 2026-02-19 |
| Q3 2025 | $1.22 | 2025-11-07 |
| Q2 2025 | $1.03 | 2025-08-07 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Life Insurance peers
MET vs 14 industry peers (Life Insurance), by market cap. Data as of close
| MET | MetLife | $64.2B | 17.69 | 0.83 | 4.7% | +0.94% |
| PRU | Prudential Financial | $40.8B | 10.42 | 0.63 | 6.0% | +1.61% |
| RGA | Reinsurance Group Of America Inc | $17.5B | 11.57 | 0.67 | 5.8% | +0.93% |
| CRBG | Corebridge Financial, Inc. | $15.6B | 17.20 | 0.78 | 4.5% | +0.60% |
| GL | Globe Life | $12.3B | 10.13 | 1.98 | 19.6% | +0.51% |
| JXN | Jackson Financial Inc. | $9.3B | 90.47 | 1.44 | 1.6% | +1.90% |
| VOYA | Voya Financial, Inc. | $9.0B | 14.81 | 1.10 | 7.4% | +1.36% |
| PRI | Primerica, Inc. | $8.7B | 11.61 | 2.54 | 21.9% | +0.93% |
| LNC | Lincoln National Corp | $8.0B | 3.38 | 0.41 | 12.2% | +1.55% |
| GNW | Genworth Financial Inc | $3.4B | 16.04 | 0.46 | 2.9% | +2.39% |
| FG | F&G Annuities & Life, Inc. | $2.8B | 6.79 | 0.47 | 6.9% | +2.65% |
| BHF | Brighthouse Financial, Inc. | $2.5B | 3.01 | 0.38 | 12.5% | -1.08% |
| CIA | CITIZENS, INC. | $189M | 16.33 | 0.74 | 4.5% | +3.60% |
| AAME | ATLANTIC AMERICAN CORP | $22M | 3.66 | 0.10 | 2.9% | +0.93% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.